nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—kidney cancer	0.245	0.587	CbGaD
Acetylsalicylic acid—RPS6KA3—Sunitinib—kidney cancer	0.193	0.582	CbGbCtD
Acetylsalicylic acid—PTGS1—kidney cancer	0.0837	0.201	CbGaD
Acetylsalicylic acid—PTGS2—kidney cancer	0.0478	0.115	CbGaD
Acetylsalicylic acid—ABCB1—kidney cancer	0.0407	0.0976	CbGaD
Acetylsalicylic acid—ABCB1—Temsirolimus—kidney cancer	0.0153	0.0463	CbGbCtD
Acetylsalicylic acid—CYP2C8—Pazopanib—kidney cancer	0.0119	0.0359	CbGbCtD
Acetylsalicylic acid—ALB—Erlotinib—kidney cancer	0.011	0.0332	CbGbCtD
Acetylsalicylic acid—CYP2C9—Capecitabine—kidney cancer	0.00865	0.0261	CbGbCtD
Acetylsalicylic acid—CYP2C8—Erlotinib—kidney cancer	0.00848	0.0256	CbGbCtD
Acetylsalicylic acid—ABCB1—Pazopanib—kidney cancer	0.00804	0.0243	CbGbCtD
Acetylsalicylic acid—CYP2C8—Paclitaxel—kidney cancer	0.00776	0.0235	CbGbCtD
Acetylsalicylic acid—ABCB1—Dactinomycin—kidney cancer	0.00736	0.0222	CbGbCtD
Acetylsalicylic acid—CYP2C8—Sorafenib—kidney cancer	0.0069	0.0208	CbGbCtD
Acetylsalicylic acid—ABCB1—Gemcitabine—kidney cancer	0.00582	0.0176	CbGbCtD
Acetylsalicylic acid—CYP2C19—Sorafenib—kidney cancer	0.00578	0.0175	CbGbCtD
Acetylsalicylic acid—ABCB1—Erlotinib—kidney cancer	0.00574	0.0173	CbGbCtD
Acetylsalicylic acid—CYP2C9—Paclitaxel—kidney cancer	0.00541	0.0164	CbGbCtD
Acetylsalicylic acid—ABCB1—Paclitaxel—kidney cancer	0.00525	0.0159	CbGbCtD
Acetylsalicylic acid—CYP2C9—Sorafenib—kidney cancer	0.00481	0.0145	CbGbCtD
Acetylsalicylic acid—ABCB1—Sorafenib—kidney cancer	0.00467	0.0141	CbGbCtD
Acetylsalicylic acid—ABCB1—Vinblastine—kidney cancer	0.00461	0.0139	CbGbCtD
Acetylsalicylic acid—ABCB1—Vincristine—kidney cancer	0.00453	0.0137	CbGbCtD
Acetylsalicylic acid—ABCB1—Sunitinib—kidney cancer	0.00378	0.0114	CbGbCtD
Acetylsalicylic acid—ABCB1—Doxorubicin—kidney cancer	0.00283	0.00856	CbGbCtD
Acetylsalicylic acid—CYP2C19—urine—kidney cancer	0.00172	0.0396	CbGeAlD
Acetylsalicylic acid—NFKBIA—nephron tubule—kidney cancer	0.0016	0.0368	CbGeAlD
Acetylsalicylic acid—HSPA5—nephron tubule—kidney cancer	0.00157	0.036	CbGeAlD
Acetylsalicylic acid—TP53—renal system—kidney cancer	0.00148	0.034	CbGeAlD
Acetylsalicylic acid—NFKBIA—renal system—kidney cancer	0.00146	0.0335	CbGeAlD
Acetylsalicylic acid—PTGS2—nephron—kidney cancer	0.00145	0.0334	CbGeAlD
Acetylsalicylic acid—TP53—kidney—kidney cancer	0.00143	0.0329	CbGeAlD
Acetylsalicylic acid—HSPA5—renal system—kidney cancer	0.00143	0.0328	CbGeAlD
Acetylsalicylic acid—NFKBIA—kidney—kidney cancer	0.00141	0.0323	CbGeAlD
Acetylsalicylic acid—TP53—cortex of kidney—kidney cancer	0.00139	0.032	CbGeAlD
Acetylsalicylic acid—HSPA5—kidney—kidney cancer	0.00138	0.0317	CbGeAlD
Acetylsalicylic acid—NFKBIA—cortex of kidney—kidney cancer	0.00137	0.0315	CbGeAlD
Acetylsalicylic acid—HSPA5—cortex of kidney—kidney cancer	0.00134	0.0308	CbGeAlD
Acetylsalicylic acid—RPS6KA3—nephron tubule—kidney cancer	0.00134	0.0307	CbGeAlD
Acetylsalicylic acid—CYP2C9—urine—kidney cancer	0.00134	0.0307	CbGeAlD
Acetylsalicylic acid—TP53—gonad—kidney cancer	0.00133	0.0305	CbGeAlD
Acetylsalicylic acid—NFKBIA—gonad—kidney cancer	0.00131	0.03	CbGeAlD
Acetylsalicylic acid—NFKBIA—cardiac atrium—kidney cancer	0.0013	0.03	CbGeAlD
Acetylsalicylic acid—HSPA5—gonad—kidney cancer	0.00128	0.0294	CbGeAlD
Acetylsalicylic acid—HSPA5—cardiac atrium—kidney cancer	0.00128	0.0293	CbGeAlD
Acetylsalicylic acid—RPS6KA3—renal system—kidney cancer	0.00121	0.0279	CbGeAlD
Acetylsalicylic acid—RPS6KA3—kidney—kidney cancer	0.00117	0.027	CbGeAlD
Acetylsalicylic acid—RPS6KA3—cortex of kidney—kidney cancer	0.00114	0.0263	CbGeAlD
Acetylsalicylic acid—RPS6KA3—cardiac atrium—kidney cancer	0.00109	0.025	CbGeAlD
Acetylsalicylic acid—EDNRA—cortex of kidney—kidney cancer	0.00093	0.0214	CbGeAlD
Acetylsalicylic acid—SLC22A6—nephron tubule—kidney cancer	0.000924	0.0212	CbGeAlD
Acetylsalicylic acid—EDNRA—cardiac atrium—kidney cancer	0.000884	0.0203	CbGeAlD
Acetylsalicylic acid—SLC22A7—renal system—kidney cancer	0.00087	0.02	CbGeAlD
Acetylsalicylic acid—IKBKB—cortex of kidney—kidney cancer	0.000844	0.0194	CbGeAlD
Acetylsalicylic acid—SLC22A7—kidney—kidney cancer	0.000841	0.0193	CbGeAlD
Acetylsalicylic acid—SLC22A7—cortex of kidney—kidney cancer	0.000819	0.0188	CbGeAlD
Acetylsalicylic acid—IKBKB—gonad—kidney cancer	0.000804	0.0185	CbGeAlD
Acetylsalicylic acid—TP53—Vincristine—Vinblastine—kidney cancer	0.000798	0.329	CbGdCrCtD
Acetylsalicylic acid—SLC22A6—cortex of kidney—kidney cancer	0.00079	0.0182	CbGeAlD
Acetylsalicylic acid—NFKBIA—Vincristine—Vinblastine—kidney cancer	0.000604	0.249	CbGdCrCtD
Acetylsalicylic acid—Salicylate-sodium—PTGS1—kidney cancer	0.000537	0.207	CrCbGaD
Acetylsalicylic acid—CYP2C8—renal system—kidney cancer	0.000368	0.00845	CbGeAlD
Acetylsalicylic acid—CYP2C8—kidney—kidney cancer	0.000356	0.00817	CbGeAlD
Acetylsalicylic acid—NFKBIA—Epirubicin—Doxorubicin—kidney cancer	0.000341	0.141	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Doxorubicin—kidney cancer	0.000341	0.141	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Doxorubicin—kidney cancer	0.000341	0.141	CbGdCrCtD
Acetylsalicylic acid—Salsalate—PTGS1—kidney cancer	0.000313	0.121	CrCbGaD
Acetylsalicylic acid—Meclofenamic acid—PTGS1—kidney cancer	0.000308	0.119	CrCbGaD
Acetylsalicylic acid—Salicylate-sodium—PTGS2—kidney cancer	0.000307	0.118	CrCbGaD
Acetylsalicylic acid—PTGS1—renal system—kidney cancer	0.000298	0.00685	CbGeAlD
Acetylsalicylic acid—PTGS1—kidney—kidney cancer	0.000288	0.00663	CbGeAlD
Acetylsalicylic acid—PTGS2—renal system—kidney cancer	0.000285	0.00655	CbGeAlD
Acetylsalicylic acid—PTGS2—kidney—kidney cancer	0.000276	0.00633	CbGeAlD
Acetylsalicylic acid—PTGS1—cardiac atrium—kidney cancer	0.000267	0.00614	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—PTGS1—kidney cancer	0.00024	0.0925	CrCbGaD
Acetylsalicylic acid—ABCB1—nephron tubule—kidney cancer	0.000194	0.00446	CbGeAlD
Acetylsalicylic acid—Salicylic acid—PTGS1—kidney cancer	0.000192	0.0742	CrCbGaD
Acetylsalicylic acid—Salsalate—PTGS2—kidney cancer	0.000179	0.069	CrCbGaD
Acetylsalicylic acid—ABCB1—renal system—kidney cancer	0.000176	0.00405	CbGeAlD
Acetylsalicylic acid—Meclofenamic acid—PTGS2—kidney cancer	0.000176	0.068	CrCbGaD
Acetylsalicylic acid—Renal impairment—Capecitabine—kidney cancer	0.000173	0.00218	CcSEcCtD
Acetylsalicylic acid—Thirst—Capecitabine—kidney cancer	0.000173	0.00218	CcSEcCtD
Acetylsalicylic acid—Shock—Everolimus—kidney cancer	0.000173	0.00217	CcSEcCtD
Acetylsalicylic acid—Anaemia—Sorafenib—kidney cancer	0.000173	0.00217	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Vinblastine—kidney cancer	0.000173	0.00217	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Everolimus—kidney cancer	0.000173	0.00216	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Everolimus—kidney cancer	0.000172	0.00216	CcSEcCtD
Acetylsalicylic acid—Purpura—Capecitabine—kidney cancer	0.000171	0.00215	CcSEcCtD
Acetylsalicylic acid—Angioedema—Sorafenib—kidney cancer	0.000171	0.00215	CcSEcCtD
Acetylsalicylic acid—ABCB1—kidney—kidney cancer	0.00017	0.00392	CbGeAlD
Acetylsalicylic acid—Hyperhidrosis—Everolimus—kidney cancer	0.00017	0.00214	CcSEcCtD
Acetylsalicylic acid—Syncope—Sorafenib—kidney cancer	0.000168	0.00211	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Sorafenib—kidney cancer	0.000168	0.0021	CcSEcCtD
Acetylsalicylic acid—Pruritus—Temsirolimus—kidney cancer	0.000168	0.0021	CcSEcCtD
Acetylsalicylic acid—Shock—Erlotinib—kidney cancer	0.000167	0.0021	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Gemcitabine—kidney cancer	0.000167	0.0021	CcSEcCtD
Acetylsalicylic acid—Anaemia—Sunitinib—kidney cancer	0.000167	0.00209	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Erlotinib—kidney cancer	0.000166	0.00209	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Gemcitabine—kidney cancer	0.000166	0.00209	CcSEcCtD
Acetylsalicylic acid—ABCB1—cortex of kidney—kidney cancer	0.000166	0.00381	CbGeAlD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.000165	0.00207	CcSEcCtD
Acetylsalicylic acid—Angioedema—Sunitinib—kidney cancer	0.000165	0.00207	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Sorafenib—kidney cancer	0.000165	0.00207	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Temsirolimus—kidney cancer	0.000162	0.00203	CcSEcCtD
Acetylsalicylic acid—Hypertension—Sorafenib—kidney cancer	0.000162	0.00203	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Sunitinib—kidney cancer	0.000161	0.00202	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Sorafenib—kidney cancer	0.00016	0.002	CcSEcCtD
Acetylsalicylic acid—ABCB1—gonad—kidney cancer	0.000158	0.00363	CbGeAlD
Acetylsalicylic acid—Pruritus—Pazopanib—kidney cancer	0.000158	0.00198	CcSEcCtD
Acetylsalicylic acid—Anaemia—Dactinomycin—kidney cancer	0.000158	0.00198	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Everolimus—kidney cancer	0.000157	0.00197	CcSEcCtD
Acetylsalicylic acid—Somnolence—Everolimus—kidney cancer	0.000157	0.00197	CcSEcCtD
Acetylsalicylic acid—Dizziness—Temsirolimus—kidney cancer	0.000157	0.00196	CcSEcCtD
Acetylsalicylic acid—Convulsion—Sunitinib—kidney cancer	0.000156	0.00196	CcSEcCtD
Acetylsalicylic acid—Hypertension—Sunitinib—kidney cancer	0.000156	0.00195	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Everolimus—kidney cancer	0.000155	0.00195	CcSEcCtD
Acetylsalicylic acid—Ulcer—Doxorubicin—kidney cancer	0.000155	0.00194	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Sunitinib—kidney cancer	0.000154	0.00193	CcSEcCtD
Acetylsalicylic acid—Chest pain—Sunitinib—kidney cancer	0.000154	0.00193	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Sorafenib—kidney cancer	0.000153	0.00192	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Dactinomycin—kidney cancer	0.000153	0.00192	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Pazopanib—kidney cancer	0.000153	0.00192	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Erlotinib—kidney cancer	0.000152	0.0019	CcSEcCtD
Acetylsalicylic acid—Vomiting—Temsirolimus—kidney cancer	0.000151	0.00189	CcSEcCtD
Acetylsalicylic acid—Shock—Sorafenib—kidney cancer	0.00015	0.00189	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Capecitabine—kidney cancer	0.00015	0.00188	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Sorafenib—kidney cancer	0.00015	0.00188	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Erlotinib—kidney cancer	0.00015	0.00188	CcSEcCtD
Acetylsalicylic acid—Rash—Temsirolimus—kidney cancer	0.000149	0.00187	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Temsirolimus—kidney cancer	0.000149	0.00187	CcSEcCtD
Acetylsalicylic acid—Dizziness—Pazopanib—kidney cancer	0.000148	0.00185	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Doxorubicin—kidney cancer	0.000147	0.00184	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Vinblastine—kidney cancer	0.000146	0.00183	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Everolimus—kidney cancer	0.000145	0.00182	CcSEcCtD
Acetylsalicylic acid—Shock—Sunitinib—kidney cancer	0.000145	0.00182	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Sunitinib—kidney cancer	0.000144	0.00181	CcSEcCtD
Acetylsalicylic acid—Melaena—Doxorubicin—kidney cancer	0.000143	0.0018	CcSEcCtD
Acetylsalicylic acid—Influenza—Capecitabine—kidney cancer	0.000143	0.00179	CcSEcCtD
Acetylsalicylic acid—Asthma—Capecitabine—kidney cancer	0.000143	0.00179	CcSEcCtD
Acetylsalicylic acid—Vomiting—Pazopanib—kidney cancer	0.000142	0.00178	CcSEcCtD
Acetylsalicylic acid—Anaemia—Vincristine—kidney cancer	0.000141	0.00177	CcSEcCtD
Acetylsalicylic acid—Rash—Pazopanib—kidney cancer	0.000141	0.00177	CcSEcCtD
Acetylsalicylic acid—Nausea—Temsirolimus—kidney cancer	0.000141	0.00177	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Pazopanib—kidney cancer	0.000141	0.00176	CcSEcCtD
Acetylsalicylic acid—Agitation—Vincristine—kidney cancer	0.00014	0.00176	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Paclitaxel—kidney cancer	0.00014	0.00175	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Paclitaxel—kidney cancer	0.000139	0.00175	CcSEcCtD
Acetylsalicylic acid—Vertigo—Vincristine—kidney cancer	0.000137	0.00172	CcSEcCtD
Acetylsalicylic acid—Mefenamic acid—PTGS2—kidney cancer	0.000137	0.0529	CrCbGaD
Acetylsalicylic acid—Leukopenia—Vincristine—kidney cancer	0.000137	0.00171	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Dactinomycin—kidney cancer	0.000136	0.00171	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Sorafenib—kidney cancer	0.000136	0.00171	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Sorafenib—kidney cancer	0.000135	0.00169	CcSEcCtD
Acetylsalicylic acid—Coma—Doxorubicin—kidney cancer	0.000134	0.00168	CcSEcCtD
Acetylsalicylic acid—Anaemia—Gemcitabine—kidney cancer	0.000134	0.00168	CcSEcCtD
Acetylsalicylic acid—Nausea—Pazopanib—kidney cancer	0.000133	0.00166	CcSEcCtD
Acetylsalicylic acid—Convulsion—Vincristine—kidney cancer	0.000132	0.00166	CcSEcCtD
Acetylsalicylic acid—Hypertension—Vincristine—kidney cancer	0.000132	0.00165	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Sunitinib—kidney cancer	0.000131	0.00165	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Vinblastine—kidney cancer	0.00013	0.00163	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Everolimus—kidney cancer	0.00013	0.00163	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Paclitaxel—kidney cancer	0.00013	0.00163	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Sunitinib—kidney cancer	0.00013	0.00163	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Gemcitabine—kidney cancer	0.00013	0.00162	CcSEcCtD
Acetylsalicylic acid—Flushing—Paclitaxel—kidney cancer	0.000129	0.00162	CcSEcCtD
Acetylsalicylic acid—Hypertension—Gemcitabine—kidney cancer	0.000125	0.00157	CcSEcCtD
Acetylsalicylic acid—Pruritus—Everolimus—kidney cancer	0.000125	0.00156	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Vincristine—kidney cancer	0.000125	0.00156	CcSEcCtD
Acetylsalicylic acid—Chest pain—Gemcitabine—kidney cancer	0.000123	0.00155	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Gemcitabine—kidney cancer	0.000123	0.00155	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Doxorubicin—kidney cancer	0.000122	0.00153	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Vincristine—kidney cancer	0.000122	0.00153	CcSEcCtD
Acetylsalicylic acid—Urticaria—Sorafenib—kidney cancer	0.000122	0.00152	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Vinblastine—kidney cancer	0.000121	0.00152	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Everolimus—kidney cancer	0.000121	0.00151	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Vincristine—kidney cancer	0.00012	0.00151	CcSEcCtD
Acetylsalicylic acid—Pruritus—Erlotinib—kidney cancer	0.00012	0.00151	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Doxorubicin—kidney cancer	0.000119	0.00149	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Gemcitabine—kidney cancer	0.000118	0.00148	CcSEcCtD
Acetylsalicylic acid—Dizziness—Vinblastine—kidney cancer	0.000117	0.00147	CcSEcCtD
Acetylsalicylic acid—Dizziness—Everolimus—kidney cancer	0.000117	0.00146	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Erlotinib—kidney cancer	0.000116	0.00146	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Gemcitabine—kidney cancer	0.000116	0.00145	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Dactinomycin—kidney cancer	0.000115	0.00144	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Capecitabine—kidney cancer	0.000115	0.00144	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Capecitabine—kidney cancer	0.000114	0.00143	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Gemcitabine—kidney cancer	0.000114	0.00143	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Sorafenib—kidney cancer	0.000113	0.00141	CcSEcCtD
Acetylsalicylic acid—Vomiting—Vinblastine—kidney cancer	0.000112	0.00141	CcSEcCtD
Acetylsalicylic acid—Dizziness—Erlotinib—kidney cancer	0.000112	0.00141	CcSEcCtD
Acetylsalicylic acid—Vomiting—Everolimus—kidney cancer	0.000112	0.00141	CcSEcCtD
Acetylsalicylic acid—Anaemia—Paclitaxel—kidney cancer	0.000112	0.0014	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Doxorubicin—kidney cancer	0.000112	0.0014	CcSEcCtD
Acetylsalicylic acid—Agitation—Paclitaxel—kidney cancer	0.000111	0.0014	CcSEcCtD
Acetylsalicylic acid—Rash—Everolimus—kidney cancer	0.000111	0.00139	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Everolimus—kidney cancer	0.000111	0.00139	CcSEcCtD
Acetylsalicylic acid—Angioedema—Paclitaxel—kidney cancer	0.000111	0.00139	CcSEcCtD
Acetylsalicylic acid—Purpura—Doxorubicin—kidney cancer	0.00011	0.00139	CcSEcCtD
Acetylsalicylic acid—Salicylic acid—PTGS2—kidney cancer	0.00011	0.0424	CrCbGaD
Acetylsalicylic acid—Hypoglycaemia—Doxorubicin—kidney cancer	0.000109	0.00137	CcSEcCtD
Acetylsalicylic acid—Vertigo—Paclitaxel—kidney cancer	0.000109	0.00137	CcSEcCtD
Acetylsalicylic acid—Syncope—Paclitaxel—kidney cancer	0.000109	0.00136	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Paclitaxel—kidney cancer	0.000108	0.00136	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Sunitinib—kidney cancer	0.000108	0.00136	CcSEcCtD
Acetylsalicylic acid—Pruritus—Sorafenib—kidney cancer	0.000108	0.00136	CcSEcCtD
Acetylsalicylic acid—Vomiting—Erlotinib—kidney cancer	0.000108	0.00136	CcSEcCtD
Acetylsalicylic acid—Rash—Erlotinib—kidney cancer	0.000107	0.00134	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Erlotinib—kidney cancer	0.000107	0.00134	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Capecitabine—kidney cancer	0.000106	0.00134	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Paclitaxel—kidney cancer	0.000106	0.00134	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000106	0.00133	CcSEcCtD
Acetylsalicylic acid—Flushing—Capecitabine—kidney cancer	0.000106	0.00133	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Gemcitabine—kidney cancer	0.000105	0.00132	CcSEcCtD
Acetylsalicylic acid—Nausea—Vinblastine—kidney cancer	0.000105	0.00132	CcSEcCtD
Acetylsalicylic acid—Somnolence—Gemcitabine—kidney cancer	0.000105	0.00132	CcSEcCtD
Acetylsalicylic acid—Convulsion—Paclitaxel—kidney cancer	0.000105	0.00132	CcSEcCtD
Acetylsalicylic acid—Nausea—Everolimus—kidney cancer	0.000105	0.00131	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Sorafenib—kidney cancer	0.000105	0.00131	CcSEcCtD
Acetylsalicylic acid—Hypertension—Paclitaxel—kidney cancer	0.000105	0.00131	CcSEcCtD
Acetylsalicylic acid—Pruritus—Sunitinib—kidney cancer	0.000104	0.00131	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Paclitaxel—kidney cancer	0.000103	0.00129	CcSEcCtD
Acetylsalicylic acid—Chest pain—Paclitaxel—kidney cancer	0.000103	0.00129	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Dactinomycin—kidney cancer	0.000103	0.00129	CcSEcCtD
Acetylsalicylic acid—Dizziness—Sorafenib—kidney cancer	0.000101	0.00127	CcSEcCtD
Acetylsalicylic acid—Nausea—Erlotinib—kidney cancer	0.000101	0.00127	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Sunitinib—kidney cancer	0.000101	0.00126	CcSEcCtD
Acetylsalicylic acid—Confusional state—Paclitaxel—kidney cancer	9.97e-05	0.00125	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Paclitaxel—kidney cancer	9.89e-05	0.00124	CcSEcCtD
Acetylsalicylic acid—Dizziness—Sunitinib—kidney cancer	9.73e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Gemcitabine—kidney cancer	9.73e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Shock—Paclitaxel—kidney cancer	9.73e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Vomiting—Sorafenib—kidney cancer	9.73e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Doxorubicin—kidney cancer	9.69e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Paclitaxel—kidney cancer	9.68e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Paclitaxel—kidney cancer	9.65e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Rash—Sorafenib—kidney cancer	9.65e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Sorafenib—kidney cancer	9.64e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Paclitaxel—kidney cancer	9.56e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Dactinomycin—kidney cancer	9.53e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Vomiting—Sunitinib—kidney cancer	9.36e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Salicylic acid—ABCB1—kidney cancer	9.35e-05	0.0361	CrCbGaD
Acetylsalicylic acid—Rash—Sunitinib—kidney cancer	9.28e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Sunitinib—kidney cancer	9.27e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Asthma—Doxorubicin—kidney cancer	9.2e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Influenza—Doxorubicin—kidney cancer	9.2e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Anaemia—Capecitabine—kidney cancer	9.19e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Vincristine—kidney cancer	9.17e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Nausea—Sorafenib—kidney cancer	9.09e-05	0.00114	CcSEcCtD
Acetylsalicylic acid—Vertigo—Capecitabine—kidney cancer	8.93e-05	0.00112	CcSEcCtD
Acetylsalicylic acid—Syncope—Capecitabine—kidney cancer	8.92e-05	0.00112	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Capecitabine—kidney cancer	8.9e-05	0.00112	CcSEcCtD
Acetylsalicylic acid—Vomiting—Dactinomycin—kidney cancer	8.86e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Paclitaxel—kidney cancer	8.82e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Somnolence—Paclitaxel—kidney cancer	8.79e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Rash—Dactinomycin—kidney cancer	8.79e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Nausea—Sunitinib—kidney cancer	8.74e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Capecitabine—kidney cancer	8.74e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Paclitaxel—kidney cancer	8.7e-05	0.00109	CcSEcCtD
Acetylsalicylic acid—Hypertension—Capecitabine—kidney cancer	8.58e-05	0.00108	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Vincristine—kidney cancer	8.52e-05	0.00107	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Capecitabine—kidney cancer	8.47e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Chest pain—Capecitabine—kidney cancer	8.47e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Pruritus—Gemcitabine—kidney cancer	8.36e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Nausea—Dactinomycin—kidney cancer	8.28e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Dizziness—Vincristine—kidney cancer	8.23e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Doxorubicin—kidney cancer	8.2e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Confusional state—Capecitabine—kidney cancer	8.18e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Paclitaxel—kidney cancer	8.15e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Gemcitabine—kidney cancer	8.08e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Shock—Capecitabine—kidney cancer	7.98e-05	0.001	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Capecitabine—kidney cancer	7.95e-05	0.000997	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Capecitabine—kidney cancer	7.92e-05	0.000993	CcSEcCtD
Acetylsalicylic acid—Vomiting—Vincristine—kidney cancer	7.92e-05	0.000993	CcSEcCtD
Acetylsalicylic acid—Sweating—Doxorubicin—kidney cancer	7.86e-05	0.000986	CcSEcCtD
Acetylsalicylic acid—Urticaria—Paclitaxel—kidney cancer	7.86e-05	0.000985	CcSEcCtD
Acetylsalicylic acid—Rash—Vincristine—kidney cancer	7.85e-05	0.000985	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Capecitabine—kidney cancer	7.84e-05	0.000984	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Vincristine—kidney cancer	7.84e-05	0.000984	CcSEcCtD
Acetylsalicylic acid—Vomiting—Gemcitabine—kidney cancer	7.51e-05	0.000942	CcSEcCtD
Acetylsalicylic acid—Rash—Gemcitabine—kidney cancer	7.45e-05	0.000934	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Gemcitabine—kidney cancer	7.44e-05	0.000933	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Doxorubicin—kidney cancer	7.4e-05	0.000928	CcSEcCtD
Acetylsalicylic acid—Nausea—Vincristine—kidney cancer	7.4e-05	0.000928	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Doxorubicin—kidney cancer	7.36e-05	0.000923	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Paclitaxel—kidney cancer	7.29e-05	0.000914	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Capecitabine—kidney cancer	7.23e-05	0.000907	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Capecitabine—kidney cancer	7.14e-05	0.000896	CcSEcCtD
Acetylsalicylic acid—Nausea—Gemcitabine—kidney cancer	7.02e-05	0.00088	CcSEcCtD
Acetylsalicylic acid—Pruritus—Paclitaxel—kidney cancer	7e-05	0.000877	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Doxorubicin—kidney cancer	6.86e-05	0.000861	CcSEcCtD
Acetylsalicylic acid—Flushing—Doxorubicin—kidney cancer	6.83e-05	0.000857	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Paclitaxel—kidney cancer	6.77e-05	0.000849	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Capecitabine—kidney cancer	6.69e-05	0.000839	CcSEcCtD
Acetylsalicylic acid—Dizziness—Paclitaxel—kidney cancer	6.54e-05	0.00082	CcSEcCtD
Acetylsalicylic acid—Urticaria—Capecitabine—kidney cancer	6.45e-05	0.000809	CcSEcCtD
Acetylsalicylic acid—Vomiting—Paclitaxel—kidney cancer	6.29e-05	0.000789	CcSEcCtD
Acetylsalicylic acid—Rash—Paclitaxel—kidney cancer	6.23e-05	0.000782	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Paclitaxel—kidney cancer	6.23e-05	0.000781	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Capecitabine—kidney cancer	5.98e-05	0.00075	CcSEcCtD
Acetylsalicylic acid—Anaemia—Doxorubicin—kidney cancer	5.92e-05	0.000743	CcSEcCtD
Acetylsalicylic acid—Agitation—Doxorubicin—kidney cancer	5.89e-05	0.000739	CcSEcCtD
Acetylsalicylic acid—Nausea—Paclitaxel—kidney cancer	5.87e-05	0.000737	CcSEcCtD
Acetylsalicylic acid—Vertigo—Doxorubicin—kidney cancer	5.76e-05	0.000722	CcSEcCtD
Acetylsalicylic acid—Syncope—Doxorubicin—kidney cancer	5.75e-05	0.000721	CcSEcCtD
Acetylsalicylic acid—Pruritus—Capecitabine—kidney cancer	5.74e-05	0.00072	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Doxorubicin—kidney cancer	5.74e-05	0.00072	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Doxorubicin—kidney cancer	5.63e-05	0.000707	CcSEcCtD
Acetylsalicylic acid—Convulsion—Doxorubicin—kidney cancer	5.55e-05	0.000697	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Capecitabine—kidney cancer	5.55e-05	0.000696	CcSEcCtD
Acetylsalicylic acid—Hypertension—Doxorubicin—kidney cancer	5.53e-05	0.000694	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Doxorubicin—kidney cancer	5.46e-05	0.000684	CcSEcCtD
Acetylsalicylic acid—Chest pain—Doxorubicin—kidney cancer	5.46e-05	0.000684	CcSEcCtD
Acetylsalicylic acid—Dizziness—Capecitabine—kidney cancer	5.37e-05	0.000673	CcSEcCtD
Acetylsalicylic acid—Confusional state—Doxorubicin—kidney cancer	5.27e-05	0.000662	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Doxorubicin—kidney cancer	5.23e-05	0.000656	CcSEcCtD
Acetylsalicylic acid—Vomiting—Capecitabine—kidney cancer	5.16e-05	0.000647	CcSEcCtD
Acetylsalicylic acid—Shock—Doxorubicin—kidney cancer	5.15e-05	0.000645	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Doxorubicin—kidney cancer	5.12e-05	0.000642	CcSEcCtD
Acetylsalicylic acid—Rash—Capecitabine—kidney cancer	5.12e-05	0.000642	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Capecitabine—kidney cancer	5.11e-05	0.000641	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Doxorubicin—kidney cancer	5.11e-05	0.00064	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Doxorubicin—kidney cancer	5.06e-05	0.000634	CcSEcCtD
Acetylsalicylic acid—Nausea—Capecitabine—kidney cancer	4.82e-05	0.000605	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Doxorubicin—kidney cancer	4.66e-05	0.000585	CcSEcCtD
Acetylsalicylic acid—Somnolence—Doxorubicin—kidney cancer	4.65e-05	0.000583	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Doxorubicin—kidney cancer	4.6e-05	0.000578	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Doxorubicin—kidney cancer	4.31e-05	0.000541	CcSEcCtD
Acetylsalicylic acid—Urticaria—Doxorubicin—kidney cancer	4.16e-05	0.000521	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Doxorubicin—kidney cancer	3.85e-05	0.000483	CcSEcCtD
Acetylsalicylic acid—Pruritus—Doxorubicin—kidney cancer	3.7e-05	0.000464	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Doxorubicin—kidney cancer	3.58e-05	0.000449	CcSEcCtD
Acetylsalicylic acid—Dizziness—Doxorubicin—kidney cancer	3.46e-05	0.000434	CcSEcCtD
Acetylsalicylic acid—Vomiting—Doxorubicin—kidney cancer	3.33e-05	0.000417	CcSEcCtD
Acetylsalicylic acid—Rash—Doxorubicin—kidney cancer	3.3e-05	0.000414	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Doxorubicin—kidney cancer	3.3e-05	0.000413	CcSEcCtD
Acetylsalicylic acid—Nausea—Doxorubicin—kidney cancer	3.11e-05	0.00039	CcSEcCtD
Acetylsalicylic acid—IKBKB—Innate Immune System—MAPK3—kidney cancer	3.22e-06	2.59e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PTEN—kidney cancer	3.19e-06	2.57e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.18e-06	2.56e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ITPR2—kidney cancer	3.16e-06	2.54e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PTEN—kidney cancer	3.15e-06	2.54e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ITPR2—kidney cancer	3.14e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.13e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—PIK3CA—kidney cancer	3.11e-06	2.51e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CDKN1B—kidney cancer	3.1e-06	2.5e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CDKN1B—kidney cancer	3.1e-06	2.5e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GSTP1—kidney cancer	3.09e-06	2.49e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—BCHE—kidney cancer	3.08e-06	2.48e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—MAPK1—kidney cancer	3.06e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—KRAS—kidney cancer	3.06e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF2—kidney cancer	3.05e-06	2.46e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CDH1—kidney cancer	3.05e-06	2.46e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—SLC5A5—kidney cancer	3.04e-06	2.45e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN2B—kidney cancer	3.04e-06	2.45e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CRABP1—kidney cancer	3.03e-06	2.44e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL2—kidney cancer	3.03e-06	2.44e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL2—kidney cancer	3.03e-06	2.44e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	3.03e-06	2.44e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.98e-06	2.4e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CRABP1—kidney cancer	2.96e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCND1—kidney cancer	2.95e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCND1—kidney cancer	2.95e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF1R—kidney cancer	2.95e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—JUN—kidney cancer	2.95e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—JUN—kidney cancer	2.95e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—SLC2A1—kidney cancer	2.94e-06	2.37e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CTNNB1—kidney cancer	2.93e-06	2.36e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CTNNB1—kidney cancer	2.93e-06	2.36e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ABCB1—kidney cancer	2.92e-06	2.36e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.91e-06	2.35e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.89e-06	2.33e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—KRAS—kidney cancer	2.89e-06	2.33e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.88e-06	2.32e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—VEGFA—kidney cancer	2.88e-06	2.32e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ACHE—kidney cancer	2.88e-06	2.32e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTT1—kidney cancer	2.88e-06	2.32e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ACHE—kidney cancer	2.86e-06	2.31e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTT1—kidney cancer	2.86e-06	2.31e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PTEN—kidney cancer	2.85e-06	2.3e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PTEN—kidney cancer	2.85e-06	2.3e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—VEGFA—kidney cancer	2.85e-06	2.3e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GSTM1—kidney cancer	2.84e-06	2.29e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN2B—kidney cancer	2.84e-06	2.29e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ITPR2—kidney cancer	2.82e-06	2.27e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—PIK3CA—kidney cancer	2.81e-06	2.27e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—KRAS—kidney cancer	2.78e-06	2.24e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CRABP1—kidney cancer	2.76e-06	2.23e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ITPR2—kidney cancer	2.75e-06	2.22e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MAPK3—kidney cancer	2.72e-06	2.2e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SCARB1—kidney cancer	2.72e-06	2.2e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—kidney cancer	2.72e-06	2.19e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SCARB1—kidney cancer	2.71e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS1—kidney cancer	2.7e-06	2.17e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MAPK3—kidney cancer	2.69e-06	2.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CYP1A1—kidney cancer	2.69e-06	2.17e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS1—kidney cancer	2.68e-06	2.16e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—PIK3CA—kidney cancer	2.66e-06	2.14e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MYC—kidney cancer	2.65e-06	2.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PSMD7—kidney cancer	2.64e-06	2.13e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PSMD7—kidney cancer	2.63e-06	2.12e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—RAF1—kidney cancer	2.62e-06	2.11e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MYC—kidney cancer	2.62e-06	2.11e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—RAF1—kidney cancer	2.6e-06	2.1e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.6e-06	2.09e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MAPK1—kidney cancer	2.59e-06	2.09e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—RELA—kidney cancer	2.59e-06	2.09e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—VEGFA—kidney cancer	2.58e-06	2.08e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—VEGFA—kidney cancer	2.58e-06	2.08e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ERBB2—kidney cancer	2.57e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ACHE—kidney cancer	2.57e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTT1—kidney cancer	2.57e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ITPR2—kidney cancer	2.57e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MAPK1—kidney cancer	2.56e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—PIK3CA—kidney cancer	2.55e-06	2.06e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MTOR—kidney cancer	2.54e-06	2.05e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD4—kidney cancer	2.53e-06	2.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTT1—kidney cancer	2.51e-06	2.02e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ACHE—kidney cancer	2.51e-06	2.02e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—BCHE—kidney cancer	2.51e-06	2.02e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—BCHE—kidney cancer	2.49e-06	2.01e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.49e-06	2.01e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SLC5A5—kidney cancer	2.48e-06	2e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SLC5A5—kidney cancer	2.46e-06	1.99e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GSTP1—kidney cancer	2.45e-06	1.98e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—KRAS—kidney cancer	2.45e-06	1.97e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MAPK3—kidney cancer	2.44e-06	1.96e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MAPK3—kidney cancer	2.44e-06	1.96e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SCARB1—kidney cancer	2.43e-06	1.96e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HIF1A—kidney cancer	2.43e-06	1.96e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TSC2—kidney cancer	2.42e-06	1.95e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—KRAS—kidney cancer	2.42e-06	1.95e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS1—kidney cancer	2.41e-06	1.94e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SLC2A1—kidney cancer	2.39e-06	1.93e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CDKN1B—kidney cancer	2.38e-06	1.92e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SLC2A1—kidney cancer	2.38e-06	1.92e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SCARB1—kidney cancer	2.37e-06	1.91e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MYC—kidney cancer	2.37e-06	1.91e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MYC—kidney cancer	2.37e-06	1.91e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.37e-06	1.91e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PSMD7—kidney cancer	2.36e-06	1.9e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS1—kidney cancer	2.35e-06	1.89e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IL2—kidney cancer	2.35e-06	1.89e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ACHE—kidney cancer	2.34e-06	1.89e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTT1—kidney cancer	2.34e-06	1.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL2—kidney cancer	2.33e-06	1.88e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KDR—kidney cancer	2.32e-06	1.87e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ABCB1—kidney cancer	2.32e-06	1.87e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.32e-06	1.87e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MAPK1—kidney cancer	2.32e-06	1.87e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MAPK1—kidney cancer	2.32e-06	1.87e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.31e-06	1.86e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PSMD7—kidney cancer	2.3e-06	1.86e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	2.27e-06	1.83e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HIF1A—kidney cancer	2.27e-06	1.83e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—JUN—kidney cancer	2.27e-06	1.83e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TSC2—kidney cancer	2.26e-06	1.82e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GSTM1—kidney cancer	2.25e-06	1.82e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CTNNB1—kidney cancer	2.25e-06	1.81e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PIK3CA—kidney cancer	2.25e-06	1.81e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—BCHE—kidney cancer	2.24e-06	1.8e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PIK3CA—kidney cancer	2.22e-06	1.79e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SCARB1—kidney cancer	2.22e-06	1.79e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SLC5A5—kidney cancer	2.21e-06	1.78e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.21e-06	1.78e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS1—kidney cancer	2.19e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PTEN—kidney cancer	2.19e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KRAS—kidney cancer	2.19e-06	1.76e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KRAS—kidney cancer	2.19e-06	1.76e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—BCHE—kidney cancer	2.18e-06	1.76e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—kidney cancer	2.18e-06	1.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SLC5A5—kidney cancer	2.16e-06	1.74e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PSMD7—kidney cancer	2.15e-06	1.74e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KIT—kidney cancer	2.14e-06	1.73e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—APC—kidney cancer	2.14e-06	1.73e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP1A1—kidney cancer	2.14e-06	1.72e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.13e-06	1.72e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SLC2A1—kidney cancer	2.08e-06	1.68e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.07e-06	1.67e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—BCHE—kidney cancer	2.04e-06	1.65e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—POMC—kidney cancer	2.04e-06	1.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.02e-06	1.63e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SLC5A5—kidney cancer	2.02e-06	1.62e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—BRAF—kidney cancer	2.01e-06	1.62e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.01e-06	1.62e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PIK3CA—kidney cancer	2.01e-06	1.62e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PIK3CA—kidney cancer	2.01e-06	1.62e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—POMC—kidney cancer	2.01e-06	1.62e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APC—kidney cancer	2e-06	1.61e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KIT—kidney cancer	2e-06	1.61e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—kidney cancer	2e-06	1.61e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTP1—kidney cancer	1.99e-06	1.61e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.99e-06	1.6e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTP1—kidney cancer	1.98e-06	1.6e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.95e-06	1.57e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—kidney cancer	1.95e-06	1.57e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—kidney cancer	1.95e-06	1.57e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.89e-06	1.52e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—MAPK3—kidney cancer	1.89e-06	1.52e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ABCB1—kidney cancer	1.89e-06	1.52e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—BRAF—kidney cancer	1.88e-06	1.51e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ABCB1—kidney cancer	1.88e-06	1.51e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MAPK3—kidney cancer	1.87e-06	1.51e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTM1—kidney cancer	1.83e-06	1.48e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTM1—kidney cancer	1.82e-06	1.47e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.81e-06	1.46e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—MAPK1—kidney cancer	1.8e-06	1.45e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MAPK1—kidney cancer	1.78e-06	1.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTP1—kidney cancer	1.78e-06	1.44e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.75e-06	1.41e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTP1—kidney cancer	1.74e-06	1.4e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP1A1—kidney cancer	1.74e-06	1.4e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP1A1—kidney cancer	1.73e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—KRAS—kidney cancer	1.7e-06	1.37e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ABCB1—kidney cancer	1.69e-06	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KRAS—kidney cancer	1.68e-06	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RAF1—kidney cancer	1.68e-06	1.35e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RELA—kidney cancer	1.67e-06	1.35e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB2—kidney cancer	1.66e-06	1.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.65e-06	1.33e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MTOR—kidney cancer	1.64e-06	1.32e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTM1—kidney cancer	1.64e-06	1.32e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTP1—kidney cancer	1.62e-06	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTGS2—kidney cancer	1.6e-06	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTM1—kidney cancer	1.6e-06	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—POMC—kidney cancer	1.59e-06	1.28e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—RAF1—kidney cancer	1.57e-06	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PIK3CA—kidney cancer	1.56e-06	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.55e-06	1.25e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB2—kidney cancer	1.55e-06	1.25e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PIK3CA—kidney cancer	1.55e-06	1.25e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN1B—kidney cancer	1.54e-06	1.24e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ABCB1—kidney cancer	1.54e-06	1.24e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MTOR—kidney cancer	1.53e-06	1.23e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD4—kidney cancer	1.53e-06	1.23e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP1A1—kidney cancer	1.51e-06	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—kidney cancer	1.51e-06	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2—kidney cancer	1.51e-06	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTM1—kidney cancer	1.49e-06	1.2e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCND1—kidney cancer	1.47e-06	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—JUN—kidney cancer	1.47e-06	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CTNNB1—kidney cancer	1.45e-06	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN1B—kidney cancer	1.44e-06	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.43e-06	1.15e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.42e-06	1.14e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTEN—kidney cancer	1.42e-06	1.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.41e-06	1.14e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTEN—kidney cancer	1.4e-06	1.12e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CTNNB1—kidney cancer	1.36e-06	1.09e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PTEN—kidney cancer	1.32e-06	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—POMC—kidney cancer	1.3e-06	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—POMC—kidney cancer	1.29e-06	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—kidney cancer	1.28e-06	1.03e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.27e-06	1.03e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAPK3—kidney cancer	1.21e-06	9.77e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MYC—kidney cancer	1.18e-06	9.5e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.16e-06	9.37e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—POMC—kidney cancer	1.16e-06	9.32e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAPK1—kidney cancer	1.15e-06	9.29e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MAPK3—kidney cancer	1.13e-06	9.11e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—POMC—kidney cancer	1.13e-06	9.1e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PTEN—kidney cancer	1.11e-06	8.93e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MYC—kidney cancer	1.1e-06	8.86e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KRAS—kidney cancer	1.09e-06	8.78e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MAPK1—kidney cancer	1.08e-06	8.67e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—POMC—kidney cancer	1.05e-06	8.5e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS2—kidney cancer	1.03e-06	8.33e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS2—kidney cancer	1.03e-06	8.28e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KRAS—kidney cancer	1.02e-06	8.19e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CA—kidney cancer	1e-06	8.06e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CA—kidney cancer	9.84e-07	7.94e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—kidney cancer	9.68e-07	7.8e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CA—kidney cancer	9.33e-07	7.52e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS2—kidney cancer	9.22e-07	7.44e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTEN—kidney cancer	9.01e-07	7.27e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS2—kidney cancer	9e-07	7.26e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTEN—kidney cancer	8.96e-07	7.22e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS2—kidney cancer	8.41e-07	6.78e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTEN—kidney cancer	8.04e-07	6.49e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTEN—kidney cancer	7.85e-07	6.33e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CA—kidney cancer	7.81e-07	6.3e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTEN—kidney cancer	7.34e-07	5.91e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CA—kidney cancer	6.36e-07	5.13e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CA—kidney cancer	6.32e-07	5.1e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CA—kidney cancer	5.68e-07	4.58e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CA—kidney cancer	5.54e-07	4.47e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CA—kidney cancer	5.17e-07	4.17e-06	CbGpPWpGaD
